The autonomy-engineering engagement
Eumenon builds company-specific operating autonomy: the memory, decision systems, tools, controls, and live operating capacity needed for work to continue without the founder in the normal path. The result is tailored to the company, from selected autonomous functions to founder-independent staff operations or broad autonomy across digital work.
Qualified independent review must confirm that sale value reached at least 2× the agreed baseline and founder operating time fell by at least 80%. If either test fails, the $200,000 contingent build fee is waived. The $25,000 Successor Foundation fee and earned $5,000 monthly fees for managed operation are not waived. Eligibility, measurement, exclusions, and obligations are fixed in signed agreements.
Eumenon builds toward real autonomy. Early live comparison produces the corrections and operating evidence needed before responsibility expands.
This is a custom autonomy-engineering engagement. The Successor Foundation defines the target and build, the monthly fee supports Eumenon's agreed ongoing role, and the contingent fee is earned only when both certified outcomes pass.
Successor Foundation
$25,000
Paid first phase: define the autonomy target, map founder dependence and operating systems, establish both baselines, and design the build, controls, and certification plan.
Managed operation
$5,000/ month
Supports Eumenon's agreed ongoing role: operating the successor, maintaining and improving a client-operated system, or sharing responsibility with the client. The work includes evaluation, correction, safeguards, and evidence capture.
Contingent build fee
$200,000
Earned only after both the 2× sale-value test and the 80% founder-time reduction test pass under the agreed independent measurement plan.
Before Eumenon accepts the full build, the Successor Foundation establishes which work should operate without the founder, what the company and its people will continue to handle, what evidence exists, and whether Eumenon can responsibly guarantee both outcomes.
The architecture and division of responsibility follow the company. Early review captures corrections and verifies performance; proven work then moves into real responsibility.
Eumenon operates and maintains the autonomy system while the client retains defined approvals, governance, and escalation authority.
The client's people operate the engineered system, memory, tools, and controls while Eumenon maintains and improves the successor.
Eumenon and the client divide operation by function or technical layer. The client may retain physical work and exceptional cases while Eumenon maintains the autonomy layer.
The system begins by observing live work, preparing recommendations, and learning from corrections. It takes on real responsibility where performance, risk, and escalation evidence support it.
Qualified independent review applies the agreed valuation and founder-time methods. Eumenon supplies the evidence; it does not make the final determinations.
A baseline valuation and certification-date valuation use an agreed method. External changes unrelated to the work are normalized so the comparison is not credited for ordinary market movement or unrelated company growth. No sale is required.
An agreed baseline period, read in the context of relevant operating history, is compared with measured founder operating time after the company-specific operating capability has held agreed outcomes stable for 90 days.
The standard engagement uses these five timing points. The signed agreement contains the exact dates and methods.
Confirm that the company and its operating history support both targets, then lock the measurement plan.
Measure founder operating time over the agreed period with relevant historical context.
Reconstruct the company, connect tools, compare early proposals with live decisions, then expand real operating responsibility as evidence supports it. The standard managed engagement continues for at least 12 months.
Hold agreed operating outcomes stable for certification.
Deadline for achieving both outcomes, subject to the signed terms.
These are the standard commercial principles. The signed agreement contains the definitive notices, exceptions, and remedies.
Eumenon is U.S.-first and generally built for established B2B companies with approximately $1 million to $10 million in normalized EBITDA, substantial judgment-heavy work performed inside the company, meaningful founder dependence, and enough digital history to connect decisions with results.